Melisron (Israel) Performance
| MLSR Stock | ILA 26,150 1,100 4.04% |
Melisron has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.42, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Melisron are expected to decrease at a much lower rate. During the bear market, Melisron is likely to outperform the market. Melisron right now secures a risk of 1.78%. Please verify Melisron maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Melisron will be following its current price movements.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Melisron are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Melisron is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 967 M | |
| Total Cashflows From Investing Activities | -543 M |
Melisron |
Melisron Relative Risk vs. Return Landscape
If you would invest 2,596,029 in Melisron on January 25, 2024 and sell it today you would earn a total of 18,971 from holding Melisron or generate 0.73% return on investment over 90 days. Melisron is generating 0.0302% of daily returns and assumes 1.7794% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than Melisron, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Melisron Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Melisron's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Melisron, and traders can use it to determine the average amount a Melisron's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.017
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MLSR |
Estimated Market Risk
| 1.78 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Melisron is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Melisron by adding it to a well-diversified portfolio.
Melisron Fundamentals Growth
Melisron Stock prices reflect investors' perceptions of the future prospects and financial health of Melisron, and Melisron fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Melisron Stock performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0317 | |||
| Profit Margin | 0.96 % | |||
| Operating Margin | 0.70 % | |||
| Current Valuation | 22.42 B | |||
| Shares Outstanding | 47.49 M | |||
| Price To Book | 1.27 X | |||
| Price To Sales | 6.96 X | |||
| Revenue | 1.42 B | |||
| EBITDA | 2.44 B | |||
| Cash And Equivalents | 1.29 B | |||
| Cash Per Share | 27.26 X | |||
| Total Debt | 9.2 B | |||
| Debt To Equity | 1.42 % | |||
| Book Value Per Share | 201.44 X | |||
| Cash Flow From Operations | 734 M | |||
| Earnings Per Share | 36.00 X | |||
| Total Asset | 24.54 B | |||
| Retained Earnings | 3.03 B | |||
| Current Asset | 401 M | |||
| Current Liabilities | 1.55 B | |||
About Melisron Performance
To evaluate Melisron Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Melisron generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Melisron Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Melisron market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Melisron's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.The company enhances, manages, maintains, and rents commercial and office spaces. Melisron Ltd. was founded in 1987 and is based in Herzliya, Israel. MELISRON operates under Real Estate Services classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 2266 people.Things to note about Melisron performance evaluation
Checking the ongoing alerts about Melisron for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Melisron help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 52.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Melisron's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Melisron's stock is overvalued or undervalued compared to its peers.
- Examining Melisron's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Melisron's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Melisron's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Melisron's stock. These opinions can provide insight into Melisron's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Melisron. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Melisron Stock analysis
When running Melisron's price analysis, check to measure Melisron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Melisron is operating at the current time. Most of Melisron's value examination focuses on studying past and present price action to predict the probability of Melisron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Melisron's price. Additionally, you may evaluate how the addition of Melisron to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |